Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
National Research Foundation of Korea Grant funded by the Korean Government (NRF-2020R1A2C1101082, J. Kim)
Institute of Information & communications Technology Planning & Evaluation (IITP-2023-RS-2023-00256629)
- License Information
-
More Information
Article History
Received: 20 August 2024
Accepted: 5 November 2024
First Online: 21 November 2024
Declarations
:
: All patients were investigated within a retrospective study evaluating the diagnostic value <sup>18</sup>F-Florbetaben PET in Alzheimer’s Disease which was approved by the Chonnam National University Hospital Ethics Committee (IRB no. CNUH 2022/394). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The local institutional review board approved this retrospective study and waived the requirement for informed consent.
: Not applicable.
: The authors declare that they have no competing interests.
